Wilfred de Vega

From MEpedia Staging, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to navigation Jump to search
Wilfred de Vega.png

Wilfred Carlo de Vega, PhD, is a Business Development Specialist at Mitacs, Toronto, Canada. He completed his doctorate in the Department of Cell & Systems Biology at the University of Toronto, Canada, under the supervision of Dr. Patrick McGowan.

Doctorate thesis[edit | edit source]

  • 2018, DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[1] - De Vega's thesis research, supervised by under the supervision of Dr. Patrick McGowan,[2] examined genome-wide epigenetic changes associated with ME/CFS and how these changes have downstream consequences on stress hormone sensitivity which could potentially relate to clinical subtypes based on symptom severity. His thesis work and ME/CFS research in the McGowan lab were funded by the Solve ME/CFS Initiative, Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Falk Medical Research Foundation. (Abstract) (Full Text)

Publications related to ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. de Vega, Wilfred Carlo (Jun 2018). "DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". TSpace - University of Toronto Libraries. 
  2. "LinkedIn - Wilfred de Vega, PhD". July 2018. 
  3. de Vega, Wilfred C.; Vernon, Suzanne D.; McGowan, Patrick O. (August 2014). "DNA Methylation Modifications Associated with Chronic Fatigue Syndrome". PLoS ONE. 9 (8): e104757. doi:10.1371/journal.pone.0104757. 
  4. de Vega, Wilfred C.; McGowan, Patrick O. (2017), "The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes", Epigenomics, 9 (11), doi:10.2217/epi-2017-0106 
  5. de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017), "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)", BMC Med Genomics, 10 (11), doi:10.1186/s12920-017-0248-3 
  6. de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018), "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome", Epigenomics, 10 (5), doi:10.2217/epi-2017-0150 
  7. Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (Dec 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769. 
  8. "ME/CFS Canadian Collaborative Team Conference" (PDF). Retrieved Mar 11, 2019. 

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.